• Mashup Score: 0

    August 17, 2022 — A study carried out by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and led by Dr. Guadalupe Sabio has identified a key role for the MKK3/6–p38γ/δ signaling pathway in the development of cardiac hypertrophy. The results, published in the journal eLife, suggest that inhibition of p38γ/δ could be a useful therapeutic strategy for diseases such as…

    Tweet Tweets with this article
    • @DAICeditor @cnic #p38 proteins regulate many processes, and their #dysregulation is linked to several #diseases, making them a promising target for drug development: https://t.co/MlwM18CXf4 #cardiachypertrophy